Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
Zomedica (OTCQB:ZOMDF) launched the Assisi Loop Lounge, a full-body targeted pulsed electromagnetic field (tPEMF) therapy bed for small animals with unlimited uses and a lifetime warranty, positioned for clinic and at-home use for osteoarthritis, chronic pain, post-surgical recovery, hospice care, and travel.
The product is promoted as peer-reviewed and evidence-backed, available through veterinarians, select retailers, and directly from Zomedica. Company highlights include 2024 revenue of $27M (+8% YoY), approximately $59M liquidity as of June 30, 2025, and cited global tPEMF market size of $400–500M in 2025 with an 8–10% CAGR to 2031.
Zomedica (OTCQB:ZOMDF) ha lanciato il Assisi Loop Lounge, un letto di terapia a campo elettromagnetico pulsato mirata al corpo intero (tPEMF) per piccoli animali, con usi illimitati e garanzia a vita, pensato per uso clinico e domestico per osteoartrite, dolore cronico, recupero post-operatorio, cure palliative e viaggi.
Il prodotto è promosso come peer-reviewed e supportato da evidenze, disponibile tramite veterinari, rivenditori selezionati e direttamente da Zomedica. I punti salienti dell'azienda includono un fatturato 2024 di $27M (+8% YoY), circa liquidità di circa $59M al 30 giugno 2025, e citato mercato globale tPEMF di $400–500M nel 2025 con un CAGR dell'8–10% fino al 2031.
Zomedica (OTCQB:ZOMDF) lanzó el Assisi Loop Lounge, una cama de terapia de campo electromagnético pulsado de cuerpo entero (tPEMF) para mascotas pequeñas, con usos ilimitados y garantía de por vida, diseñada para uso en clínica y en casa para la osteoartritis, dolor crónico, recuperación posquirúrgica, cuidados paliativos y viajes.
El producto se promociona como revisado por pares y respaldado por evidencias, disponible a través de veterinarios, minoristas selectos y directamente de Zomedica. Los puntos destacados de la empresa incluyen ingresos de 2024 de $27M (+8% interanual), aproximadamente liquidez de ~$59M al 30 de junio de 2025, y un mercado global de tPEMF estimado en $400–500M en 2025 con una CAGR del 8–10% hasta 2031.
Zomedica (OTCQB:ZOMDF) 는 Assisi Loop Lounge 를 출시했으며, 소동물용 전체 신체 표적 펄스 전자기장(tPEMF) 치료 침대, 사용 무한 및 평생 보증이 제공되며 임상 및 가정용으로 골관절염, 만성 통증, 수술 후 회복, 완화 치료, 여행에 맞춰 설계되었습니다.
이 제품은 동료 평가(peer-reviewed) 및 근거에 기반한다고 홍보되며 수의사, 선택 소매업체, Zomedica에서 직접 구입 가능하며, 회사의 하이라이트로는 2024년 수익 $27M(+8% YoY), 대략 2025년 6월 30일 기준 유동성 $59M, 그리고 글로벌 tPEMF 시장 규모를 $400–500M로 제시하고 2031년까지 8–10% CAGR으로 예측합니다.
Zomedica (OTCQB:ZOMDF) a lancé le Assisi Loop Lounge, un lit de thérapie par champ électromagnétique pulsé ciblé sur tout le corps (tPEMF) pour petits animaux, avec des usages illimités et une garantie à vie, conçu pour un usage en clinique et à domicile pour l’arthrose, la douleur chronique, la récupération post-opératoire, les soins palliatifs et les voyages.
Le produit est promu comme revu par des pairs et appuyé par des preuves, disponible par le biais de vétérinaires, de détaillants sélectionnés et directement auprès de Zomedica. Points forts de l’entreprise : revenus 2024 de 27 M$ (+8% YoY), environ liquidité de ~59 M$ au 30 juin 2025, et un marché tPEMF global estimé à 400–500 M$ en 2025 avec une cagr de 8–10% jusqu’en 2031.
Zomedica (OTCQB:ZOMDF) hat das Assisi Loop Lounge eingeführt, ein ganzkörperliches, zielgerichtetes Puls-Elektromagnetfeld (tPEMF) Therapiebett für Kleintiere mit unbegrenzten Nutzungsmöglichkeiten und lebenslanger Garantie, konzipiert für Klinik- und Heimgebrauch bei Osteoarthritis, chronischen Schmerzen, postoperativer Erholung, Palliativpflege und Reisen.
Das Produkt wird als peer-reviewed und evidenzgestützt beworben, erhältlich über Tierärzte, ausgewählte Einzelhändler und direkt von Zomedica. Highlights des Unternehmens umfassen 2024er Umsatz von 27 Mio. $ (+8% YoY), ca. Liquidität von ca. 59 Mio. $ zum 30. Juni 2025 und eine angegebene globale tPEMF-Marktnachfrage von 400–500 Mio. $ im Jahr 2025 mit einer CAGR von 8–10% bis 2031.
Zomedica (OTCQB:ZOMDF) أطلقت Assisi Loop Lounge، سرير علاج بتردد مغناطيسي نبضي موجه للجسم بالكامل (tPEMF) للحيوانات الصغيرة مع استخدامات غير محدودة وضمان مدى الحياة، مصمم للاستخدام في العيادات والمنزل من أجل التهاب المفاصل العظمي، الألم المزمن، التطور بعد الجراحة، رعاية نهاية الحياة والسفر.
يُروّج للمنتج كأنه خاضع للمراجعة من الأقران ومساند بالأدلة، ومتوافر عبر البيطريين وتجار التجزئة المختارين وبشكل مباشر من Zomedica. تشمل نقاط الشركة البارزة إيرادات 2024 تبلغ 27 مليون دولار (+8% على أساس سنوي)، حوالي سيولة تبلغ نحو 59 مليون دولار حتى 30 يونيو 2025، ومصدر سوق tPEMF العالمي المذكور بحجم 400–500 مليون دولار في 2025 مع معدل نمو سنوي مركب من 8–10% حتى 2031.
Zomedica (OTCQB:ZOMDF) 推出了 Assisi Loop Lounge，一款面向全身的定向脉冲电磁场治疗床（tPEMF），适用于小型动物，使用无限制且提供终身保修，面向诊所和家庭使用，适用于骨关节炎、慢性疼痛、术后恢复、临终关怀与旅行。
该产品被宣传为经过同行评审并有证据支持，可通过兽医、精选零售商以及直接从 Zomedica 购买。公司亮点包括 2024 年收入 2700 万美元（同比增长 8%）、大约 截至 2025 年 6 月 30 日的流动性约为 5900 万美元，以及所提及的全球 tPEMF 市场规模在 2025 年为 4–5 亿美元，并预测到 2031 年的 8–10% 的复合年增长率（CAGR）。
- Revenue +8% in 2024 to $27M
- Liquidity approximately $59M as of June 30, 2025
- Assisi tPEMF supported by >10 years of peer-reviewed research
- Global tPEMF market estimated $400–500M in 2025 with 8–10% CAGR
- 2024 revenue modest at $27M versus U.S. TAM >$2B
- Commercial expansion depends on strategic acquisitions and international rollout
Insights
Launch expands a scientifically backed therapeutic portfolio but offers limited hard financial detail to assess immediate material impact.
Zomedica announced the Assisi Loop Lounge on
The communication ties the launch to a stated global animal‑health tPEMF market of
Watchable, concrete items and time horizons disclosed include product availability channels now and the market growth window through
Combining peer-reviewed science, superior comfort, and thoughtful design, the Assisi Loop Lounge expands Zomedica's evidence-based therapeutic portfolio and reinforces Assisi's leadership in targeted tPEMF innovation
ANN ARBOR, MI / ACCESS Newswire / October 23, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the launch of the Assisi Loop Lounge, a next-generation targeted pulsed electromagnetic field (tPEMF) therapy bed delivering full-body treatment and luxurious comfort for pets, now featuring unlimited uses and a lifetime warranty to provide lasting therapeutic value for pet owners and veterinary professionals alike.
The Assisi Loop Lounge is the only small animal tPEMF device backed by peer-reviewed scientific research, making it the trusted choice of veterinarians and pet owners worldwide. Recognized globally as the leader in evidence-based tPEMF therapy, the Assisi brand continues to redefine non-invasive healing for companion animals through scientifically validated technology and exceptional user experience.
"Not all tPEMF devices are created equal," said Nicole Westfall, Senior Vice President of Marketing at Zomedica. "The Assisi Loop Lounge combines scientifically proven tPEMF technology preferred, trusted, and recommended in veterinary medicine with a beautifully designed, comfortable solution that pet owners feel good about bringing into their homes. It's truly where science meets love™."
Versatile Healing-From Clinics to Homes and Beyond
The Assisi Loop Lounge is used by veterinary clinics to relieve pain and inflammation during treatment and recovery. In hospice and palliative care, it provides gentle comfort for pets nearing the end of life. At home, pet parents use the Lounge daily for the management of osteoarthritis, chronic pain, post-surgical recovery, and overall mobility support.
Its lightweight, portable design makes it ideal for long car rides and travel, fitting easily into most pet carriers to provide therapeutic comfort on the go. Available in multiple sizes, the Lounge is suitable for dogs, cats, rabbits, and even exotic animals, offering a compassionate solution for a wide range of species and needs.
Unlimited Treatments, Lifetime Warranty
With unlimited treatments and a lifetime warranty, the Loop Lounge delivers unmatched long-term reliability and peace of mind. This ensures continuous therapeutic support throughout a pet's lifetime, reinforcing Zomedica's commitment to quality, durability, and animal wellness.
Constructed with three inches of premium orthopedic foam, a liquid-resistant liner, and a performance fabric cover, the Lounge provides an ideal blend of comfort and functionality for pets recovering from injury, living with chronic conditions, or simply aging gracefully.
Mialisa Gluckert, Senior Director of Commercialization at Zomedica, added, "The Loop Lounge reinforces our leadership in therapeutic innovation. As the only scientifically backed tPEMF device in the small animal market, Assisi continues to set the benchmark for evidence-based healing. Veterinarians choose it for its proven efficacy; pet owners choose it because they see the difference in their animals' comfort, recovery, and quality of life."
Trusted by Rehabilitation Experts
"As a rehabilitation veterinarian, the Assisi Loop Lounge is a critical component of my practice," said Dr. Matthew Brunke, DVM, DACVSMR (Canine), CCAT, Fellow, IAVRPT. "It provides consistent, evidence-based pain relief and accelerates recovery for my patients. Whether in the clinic or at home, it gives veterinarians and owners a safe, effective tool to improve quality of life and support long-term healing."
Expanding Market Opportunity
The global animal-health tPEMF and electrotherapy market is valued at approximately
Assisi products are supported by more than a decade of peer-reviewed research demonstrating the clinical benefits of targeted pulsed electromagnetic field therapy in reducing inflammation, accelerating healing, and improving mobility in companion animals. The Assisi Loop Lounge reflects Zomedica's dedication to delivering technologies "where science meets love."
Learn more about the Assisi Loop Lounge at www.assisianimalhealth.com and get yours today. Now available through veterinarians, select online retailers, and directly from Zomedica.
About Zomedica
Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians with innovative therapeutic and diagnostic solutions. Our gold standard PulseVet® shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi Loop® line of therapeutic devices, the TRUFORMA® diagnostic platform, the TRUVIEW® digital cytology system, the VETGuardian® no-touch monitoring system, and VETIGEL® hemostatic gel, a revolutionary hemostatic gel that rapidly stops bleeding-each designed to empower veterinarians to deliver top-tier care. In the aggregate, their total addressable market in the U.S. exceeds
Follow Zomedica
Email Alerts: http://investors.zomedica.com
Facebook: https://m.facebook.com/zomedica
X (formerly Twitter): https://twitter.com/zomedica
Instagram: https://www.instagram.com/zomedica_inc
Cautionary Note Regarding Forward-Looking Statements
Except for statements of historical fact, this news release contains certain "forward-looking information" or "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur and include statements relating to our expectations regarding future results. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance, or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information.
Forward-looking information is based on the opinions and estimates of management at the date the statements are made, including assumptions with respect to economic growth, demand for the Company's products, the Company's ability to produce and sell its products, sufficiency of our budgeted capital and operating expenditures, the satisfaction by our strategic partners of their obligations under our commercial agreements and our ability to realize upon our business plans and cost control efforts.
Our forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: the outcome of clinical studies, the application of generally accepted accounting principles, which are highly complex and involve many subjective assumptions, estimates, and judgments, uncertainty as to whether our strategies and business plans will yield the expected benefits; uncertainty as to the timing and results of development work and verification and validation studies; uncertainty as to the timing and results of commercialization efforts, including international efforts, as well as the cost of commercialization efforts, including the cost to develop an internal sales force and manage our growth; uncertainty as to our ability to realize the anticipated growth opportunities from our acquisitions; uncertainty as to our ability to supply products in response to customer demand; supply chain risks associated with tariff changes; uncertainty as to the likelihood and timing of any required regulatory approvals, and the availability and cost of capital; the ability to identify and develop and achieve commercial success for new products and technologies; veterinary acceptance of our products and purchase of consumables following adoption of our capital equipment, particularly in Europe; competition from related products; the level of expenditures necessary to maintain and improve the quality of products and services; changes in technology and changes in laws and regulations; our ability to secure and maintain strategic relationships; performance by our strategic partners of their obligations under our commercial agreements, including product manufacturing obligations; risks pertaining to permits and licensing, intellectual property infringement risks, risks relating to any required clinical trials and regulatory approvals, risks relating to the safety and efficacy of our products, the use of our products, intellectual property protection, and the other risk factors disclosed in our filings with the SEC and under our profile on SEDAR+ at www.sedarplus.com. Readers are cautioned that this list of risk factors should not be construed as exhaustive.
The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information.
Investor Relations Contact:
Zomedica Investor Relations
Investors@zomedica.com
1-734-369-2555
SOURCE: Zomedica Corp.
View the original press release on ACCESS Newswire
FAQ
What is the Assisi Loop Lounge launched by Zomedica (ZOMDF) on October 23, 2025?
How much revenue did Zomedica (ZOMDF) report for 2024 and what was the growth rate?
What liquidity did Zomedica (ZOMDF) report as of June 30, 2025?
What is the cited market opportunity for animal-health tPEMF products mentioned with the Loop Lounge?
Where can pet owners and veterinarians buy the Assisi Loop Lounge from Zomedica (ZOMDF)?
